Skip to content
Screener

Roivant Sciences ROIV Q3 2024 earnings

Reported February 10, 2025 · Before market open

Revenue$9.0MMiss by $53.1M
EPS-$0.13Beat by $0.11
Revenue estimate$62.2M
EPS estimate-$0.24

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$3.4M
EPS estimate-$0.41

Financials

Q3 2024

Income statement

See full
Revenue$9.0M-42.1%
Operating income-$274.4M-105%
Net income$169.4M-96.7%
EPS (diluted)$0.23-96.2%

Balance sheet

See full
Cash & equivalents$99.1M-98.5%
Total debt$100.3M-80.2%
Total equity$5.2B-14.8%
Total assets$5.8B-20.8%

Cash flow

See full
Operating cash flow-$207.3M+1.5%
CapEx$1.8M+415%
Free cash flow-$209.1M+0.8%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$8.61B-4.2%
Enterprise value$8.61B+206%
P/E249.7×+248×
P/S282.3×+62.1×

Profitability

See full
Operating margin-2,354.9%-13,711pp
Net margin113.1%-10,825pp
FCF margin-2,555.4%+826pp

Returns & leverage

See full
Return on equity0.6%-126pp
Debt / equity0×-0.1×
Current ratio37.9×+10.1×

Segments

By segment

See full
Reportable Segment$9.0M+10.3%

FAQ

When did Roivant Sciences report Q3 2024 earnings?
Roivant Sciences (ROIV) reported Q3 2024 earnings on February 10, 2025 before market open.
What were Roivant Sciences's Q3 2024 revenue and EPS?
Roivant Sciences reported revenue of $9.0M and eps of $-0.13 for Q3 2024.
Did Roivant Sciences beat estimates in Q3 2024?
Revenue missed the consensus estimate of $62.2M by $53.1M. EPS beat the consensus estimate of $-0.24 by $0.11.
Where can I find Roivant Sciences's Q3 2024 SEC filings?
You can read the 8-K earnings release (0001140361-25-003639) and the 10-Q periodic report (0001140361-25-003661) directly on SEC EDGAR. The filing index links above go to sec.gov.